Sanofi 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
SA Sanofi | Institutional Filer | ▲ 8.23% | $336.0M | 9 |
Current Portfolio Holdings
Showing all 9 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | MGTX | MeiraGTx Holdings plc | Healthcare | 12.2M | $105.6M | 31.44% |
| 2 | INBX | Inhibrx Biosciences, Inc. | Healthcare | 1.2M | $77.8M | 23.17% |
| 3 | NVAX | Novavax, Inc. | Healthcare | 6.9M | $56.0M | 16.67% |
| 4 | ANAB | AnaptysBio, Inc. | Healthcare | 822K | $30.4M | 9.04% |
| 5 | AGMB | Agomab Therapeutics NV | — | 2.8M | $29.2M | 8.69% |
| 6 | MPLT | MapLight Therapeutics, Inc. | — | 912K | $18.5M | 5.52% |
| 7 | IMRX | Immuneering Corporation | Healthcare | 2.7M | $14.3M | 4.25% |
| 8 | ELDN | Eledon Pharmaceuticals, Inc. | Healthcare | 815K | $2.5M | 0.75% |
| 9 | QTTB | Q32 Bio Inc. | Healthcare | 244K | $1.6M | 0.47% |
Showing 1 to 9 of 9 holdings